Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin vs Unfractionated Heparin in High Risk NSTE-ACS
NCT00435487Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Jun 2007
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dalteparin in Non-ST elevation acute coronary syndrome (NSTE-ACS), sponsored by Pfizer. Started Jun 2007; status: terminated.
02
Drugs
dalteparin
03
Conditions
Non-ST elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT00435487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435487.